My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


General Motors' Potential In EV Transformatio...
What Analysts Are Saying About PepsiCo's Q1 E...
US Supreme Court To Weigh Starbucks Challenge...
Meta Platforms Q1 Earnings Preview: 'Marginal...
Apple Sets Date for Special Event After 18-Mo...
Can Electronic Arts Overcome Gaming Headwinds...
Ford Enjoys Bullish Momentum, Faces Buying Pr...
Biden's Old '0% Inflation' Comment Comes Back...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) (NYSE: NVS)

    Overview
    current price
    $97.28
    $97.28
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    97.28
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    1.59 M
    1 day
    0.00 - 0.00
    52 weeks
    92.19 - 108.78
    p/e
    23.55
    beta
    0.5085
    market cap
    213.04 B
    dividend yield
    3.33%
    Industry
    -
    NVS by TradingView
    News and Commentary
    Market Update: Dow Climbs 260 Points on Strong Second-Quarter Earnings Stocks climbed higher on Tuesday as the second-quarter earnings season delighted investors, helping to build on gains from the prior session. The Dow Jones Industrial Average ros...
    Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Mar... After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-declining trend.
    Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administrati...
    Novartis Sandoz Prepares For Public Debut With Strong Sales Record And Plans for New Biologic Drugs Novartis AG (NVS 
    From Years to Months: How AI is Shaping the Landscape of Clinical Trials Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significan...
    AI Integration In Biotech & Pharma: Companies Positioned To Benefit The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug dis...
    Biden Administration Vs. Big Pharma: What the Legal Showdown Means for Your Wallet The Biden administration's move to lower drug prices has prompted a flurry of legal challenges. While legal experts acknowledge the lack of a clear legal precedent, signs suggest...
    Novartis Q2 Earnings: Company Lifts Outlook, Launches $15B Share Buyback, Maps Out Sandoz Spin-Off Novartis AG (NVS 
    Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink Bausch + Lomb Corporation (BL...
    Drug Makers Inflated Pandemic-Era Prices by Billions Without Cause, Report Says Provisions in President Joe Biden's proposed $1.75 trillion social spending package would put a
    StockTwits
    StockTwits
    Most Shared
    Elon Musk's Social Media Platform To Launch X TV App
    Not Just Nvidia, AI Is Also Fueling Global Copper Demand: Analyst Reveals 3 Top Stock Picks
    Binance Has 'Moved Past' Its Old Ways, Says CEO Richard Teng
    Most Popular
    Carnival Q1 Earnings Reflect Pricing Strength Analyst Says: 'Solid Beat Across The Board'
    Inflation Rises More Than Expected To 3.5% In March, Derails June Rate Cut Hopes
    Not Just Nvidia, AI Is Also Fueling Global Copper Demand: Analyst Reveals 3 Top Stock Picks
    popular tags
    Earnings
    Coronavirus
    Coronavirus Impact
    Amazon
    Apple
    Covid-19
    Covid19
    Google
    China
    mobile iOS Android
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2024 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?